Akèy › Psoryaz › Indiana › Indianapolis
Etid klinik pou Psoryaz nan Indianapolis, IN
3 etid pou Psoryaz ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Ap rekriteFaz 3
- Vanda Investigational Site, Indianapolis
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · 14 mi lwen
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Ap rekriteFaz 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Etid Psoryaz nan lòt vil
- Trenton, NJ7 etid
- Newton, MA6 etid
- Cleveland, OH6 etid
- Philadelphia, PA5 etid
- New York City, NY5 etid
- San Antonio, TX5 etid
- Fremont, CA5 etid
- Huntington Beach, CA4 etid
- Birmingham, AL4 etid
- San Diego, CA3 etid
- Rochester, NY3 etid
- Columbus, OH3 etid
Lòt etid nan Indianapolis
- Kansè Poumon ki pa ti selil32 etid
- Kansè (tout kalite)24 etid
- Ensifizyans kadyak23 etid
- Kansè nan tete20 etid
- Obèsite20 etid
- Kansè Metastatik19 etid
- Kansè kolorektal18 etid
- Kansè ovè17 etid
- Kansè poumon16 etid
- Maladi kadyovaskilè16 etid
- Dyabèt tip 114 etid
- Kansè Endomèt14 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.